Page 7 - Mankind Pharma

Mankind Pharma signs agreement to buy Panacea Biotec Pharma's domestic biz

Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in FY21; Adar Poonawalla holds 8.6% stake in the firm

Covid-19 & low base in 2020 boost anti-infectives growth, shows data

Antibiotics, antivirals spur drug category; chronic therapies post lower numbers

Mankind, BDR Pharma join hands to launch anti Covid-19 pill Molulife

Mankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti COVID-19 pill Molulife (Molnupiravir) in the country. The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion, distribution is by Mankind Pharma, the company said in a statement. On Tuesday, the Drugs Controller General of India (DCGI) granted permission for restricted use of antiviral medication Molnupiravir under emergency situation for treatment of COVID-19 in adult patients who have a high risk of progression of the disease. This launch further enhances the COVID-19 treatment portfolio in BDR's product basket with the addition of generic Molnupiravir. We are pleased to collaborate with Mankind Pharma to take one step forward in fighting the virus," BDR Pharma Director Business Development Raheel Shah stated. Mankind Pharma Senior President (Sales & Marketing) Sanjay Koul noted that a pill for COVID-19 is bound to go miles in ...

Mankind Pharma inks distribution pact with BDR Pharma for Covid drug

Delhi-based Mankind Pharma operates in 34 overseas destinations.

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Mankind Pharma may partner RDIF for Russian Covid-19 vaccine Sputnik V

According to sources close to the development, talks are in advanced stages between Mankind Pharma and RDIF

Domestic drug market growth slows top 4.5% in January, some therapies drag

Respiratory segment and anti-infectives contract; Cardiac, anti-diabetic growth rates plummet

Mankind Pharma partners with South Korea's Daewoong for Covid drug

Will conduct clincial trials on anti-parasitic drug they claim is more effective than remdesivir

Mankind Pharma eyes acquisition of biotech firms, plans new launches

Mankind became the first Indian and second global company to develop a dydrogesterone containing drug for treatment of pregnancy-related complications

Mankind Pharma looking to achieve $1-bn turnover by 2021: Official

It has recently ventured into the US market with the filing of 12-15 ANDAs every year

Mankind Pharma set to foray into diagnostics with Pathkind

The company's initial focus will be Uttar Pradesh followed by Uttarakhand, Bihar, and North-East